Pharmaceutical industry news

U.S. FDA warning prompts Taiwan red alert over heart pump device

Argenx Has Delivered 18 Consecutive Quarters of Sales Growth -- but Is the Biotech Stock Still Underrated?

Royal Bank of Canada Reduces Stock Position in Ultragenyx Pharmaceutical Inc. $RARE

Heidelberg Geoinformation Scientists Classify Global Road Networks

La AEMPS retira varios productos adelgazantes por contener sibutramina, un principio activo no autorizado en la UE por sus efectos adversos graves

How BioMarin’s Navepegritide Settlement and Royalty Deal with Ascendis Could Shape BioMarin (BMRN) Investors

Incyte shifts to multi-franchise biotech with 1...

Novartis breaks BTK losing streak in multiple sclerosis

Why is Simcere Pharmaceutical stock surging today? By Investing.com

The biggest biotech funding rounds in August 2026

Why is Simcere Pharmaceutical stock surging today?

50 ans de pharmacovigilance en Belgique : Save the Date

Pharma companies warn Greek prime minister medicine financing model has 'reached its limits'

Seamless pharma solutions at CPHI Milan

Why is Simcere Pharmaceutical stock surging today?

Medipost Recruits Samsung Biologics Veteran Min Ho-sung as President to Accelerate Cartistem Global Expansion

Heparegenix wins orphan drug status for darizmetinib

FSSAI chief roots for Tukaram Mundhe, says food safety is not punishment posting

Ono Pharmaceutical partners with Aitia to hunt new brain-disease drug targets using causal AI

From his parents’ basement to your medicine cabinet: Absci CEO endeavors to create biotech’s Apple

Warning for MyChart users: New scam impersonates the patient portal

Pediatric Mobile Clinic provides free vision screenings and evaluations for Folsom Cordova district students

Can the Biotech Act deliver for Europe ?

South Korea creates quasi-innovative tier to boost R&D-driven drugmakers - CHOSUNBIZ

Pharmaceutical Industry Public-Private Consultative Body Launched... Stepwise Promotion from "Innovative" to "Global"

Ultragenyx Pharmaceutical (RARE) Wins FDA Approval, Is The Stock Fully Priced?

Legend Biotech (LEGN) Heads To Morgan Stanley Conference, Is The 57% Valuation Gap Justified?

Novartis BTK pill cuts MS relapses without liver risk, lifts shares 6% - CHOSUNBIZ

Ultragenyx Pharmaceutical (RARE) After FDA Approval, Is The Gene Therapy Win Already Priced In?

IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications

Tectonic Therapeutic: Competitor Data Strengthens The TX45 Bull Case

Stripped of AstraZeneca safety net, BMS could face ‘carnage’ if high-risk clinical trial fails

Should FDA Approval Of MIMRYLO Reshape How Investors View Takeda Pharmaceutical’s (TSE:4502) Rare-Disease Strategy?

Biotech Is Popping. No One Seems to Care.

Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations

Early Alert: Convenience Kit Issue from AVID Medical

AVID Medical is correcting convenience kits containing recalled Huons Co. sodium chloride ampules.

Convenience Kit Correction: Medline Issues Correction for Convenience Kits Containing BD ChloraPrep Applicators

Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.

Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Catheters

Certain reprocessed catheters may contain residual particulates that could cause infection, embolism...

EIB Approves $10B Renewable Infrastructure, Biotech Funding

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?

Recce Pharmaceuticals advances R327 as diabetes and antibiotic resistance burdens converge

Millions Take Zyrtec Daily, and Stopping After Months of Use Can Trigger Severe Itching in Rare Cases

C. diff Prevention Vaccine Enters Vermont Clinical Trials

Battelle Researchers Demonstrate Biotech Breakthrough for Rare Earth Element Separation

Simcere Pharmaceutical Partners with Roche in Trispecific Antibody Licensing Deal Worth Up to $1.53 Billion

Haier Biomedical Highlights Automated Biostorage and Connected Pharma Solutions at ISPE Singapore 2026

Biotech And Medtech Stocks Sold Off On Bad News

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Inside Biotech: ENA Respiratory secures A$2.98 million to advance INNA-051 asthma study

US states’ lawsuit seeking to curb abortion drug access paused for now

Sumitomo Pharma Announces Personnel Changes

Stonepine Capital Management, LLC Expands Edesa Biotech Inc (EDSA) Stake with Strategic Add

OPDP’s Latest Reminder on Preapproval Promotion

Recce Pharmaceuticals Holds General Meeting Ahead of September 2026 Phase 3 Trial Interim Data Readout

Optogenetic vision restoration: translational barriers and emerging therapeutic strategies

Prospective Grant of an Exclusive Patent License: Development and Commercialization of Mifepristone and Analogues To Treat Hypercortisolism-Related Insulin Resistance Disorders

The National Institute of Diabetes and Digestive and Kidney Diseases, an institute of the National I...

Submission for Office of Management and Budget Review; TANF Contingency Fund Application

The Office of Family Assistance, Administration for Children and Families (ACF), U.S. Department of...

Agency Information Collection Activities: Submission for OMB Review; Comment Request

The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to co...

Determination That CARAFATE (Sucralfate) Oral Suspension, 1 Gram/10 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness

The Food and Drug Administration (FDA, Agency, or we) has determined that CARAFATE (sucralfate) oral...

Pharmacokinetics in Patients With Impaired Hepatic Function: Study Design, Data Analysis, and Impact on Dosage; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for indust...